BR112021022896A2 - Método de seleção de regimes, ingredientes e composições de tratamento de pele - Google Patents

Método de seleção de regimes, ingredientes e composições de tratamento de pele

Info

Publication number
BR112021022896A2
BR112021022896A2 BR112021022896A BR112021022896A BR112021022896A2 BR 112021022896 A2 BR112021022896 A2 BR 112021022896A2 BR 112021022896 A BR112021022896 A BR 112021022896A BR 112021022896 A BR112021022896 A BR 112021022896A BR 112021022896 A2 BR112021022896 A2 BR 112021022896A2
Authority
BR
Brazil
Prior art keywords
ingredients
compositions
skin care
selecting skin
care regimens
Prior art date
Application number
BR112021022896A
Other languages
English (en)
Other versions
BR112021022896A8 (pt
Inventor
Georgios Stamatas
Janeta Nikolovski
Kimberly Capone
Lorena Telofski
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of BR112021022896A2 publication Critical patent/BR112021022896A2/pt
Publication of BR112021022896A8 publication Critical patent/BR112021022896A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders

Abstract

método de seleção de regimes, ingredientes e composições de tratamento de pele. a presente invenção revela um método de seleção de regimes, ingredientes e composições de tratamento de pele que inclui a medição dos níveis de metabólitos de moléculas pequenas específicos sobre a pele antes e depois da aplicação do produto, bem como o teste de uma alteração nos níveis de metabólitos de moléculas pequenas.
BR112021022896A 2019-05-15 2020-05-12 Método de seleção de regimes, ingredientes e composições de tratamento de pele BR112021022896A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962848042P 2019-05-15 2019-05-15
PCT/IB2020/054442 WO2020230007A1 (en) 2019-05-15 2020-05-12 Method of selecting skin treatment regimens, ingredients and compositions

Publications (2)

Publication Number Publication Date
BR112021022896A2 true BR112021022896A2 (pt) 2022-01-25
BR112021022896A8 BR112021022896A8 (pt) 2022-10-11

Family

ID=70804857

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021022896A BR112021022896A8 (pt) 2019-05-15 2020-05-12 Método de seleção de regimes, ingredientes e composições de tratamento de pele

Country Status (9)

Country Link
US (1) US11642300B2 (pt)
EP (1) EP3969903A1 (pt)
KR (1) KR20220009424A (pt)
CN (1) CN113906297A (pt)
AU (1) AU2020274637A1 (pt)
BR (1) BR112021022896A8 (pt)
CA (1) CA3140604A1 (pt)
MX (1) MX2021013956A (pt)
WO (1) WO2020230007A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022345529A1 (en) * 2021-09-16 2024-03-14 Centra Inria De I'universite Cote D'azur Analysis and characterization of epithelial tissue structure
WO2023144701A1 (en) 2022-01-28 2023-08-03 Johnson & Johnson Consumer Inc. Biomarkers predictive of atopic dermatitis
WO2023194839A1 (en) 2022-04-04 2023-10-12 Donnelly Window of opportunity skin treatment regimen and composition for preventing the onset of or treating atopic dermatitis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792728B1 (fr) * 1999-04-20 2003-05-09 Oreal Procede d'evaluation de l'effet d'un produit sur la lipogenese de l'epiderme
FR2798591B1 (fr) 1999-09-22 2001-10-26 Pharmascience Lab Utilisation d'un produit d'huile vegetale pour augmenter la synthese des lipides cutanes en cosmetique, pharmacie ou dermatologie et en tant qu'additif alimentaire
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020182112A1 (en) 2001-04-30 2002-12-05 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. In vivo method for measuring binding of chemical actives to skin or specific constituents of skin
US7183057B2 (en) * 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
WO2008033575A2 (en) 2006-09-15 2008-03-20 Metabolon, Inc. Methods of identifying biochemical pathways
WO2011087525A1 (en) * 2010-01-17 2011-07-21 The Procter & Gamble Company Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
US9671410B2 (en) * 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
US10573406B2 (en) 2013-01-15 2020-02-25 Metabolon, Inc. Method, apparatus and computer program product for metabolomics analysis
AU2014364539B2 (en) 2013-12-20 2019-08-01 Metabolon, Inc. Biomarkers of de novo lipogenesis and methods using the same" (i.e. change Biomakers to Biomarkers)
ES2825105T3 (es) 2014-04-08 2021-05-14 Metabolon Inc Obtención del perfil bioquímico de moléculas pequeñas de sujetos individuales para el diagnóstico de enfermedad y evaluación de la salud
US20180185255A1 (en) * 2017-01-05 2018-07-05 The Procter & Gamble Company Method of Selecting Mild Skin Cleansers

Also Published As

Publication number Publication date
CN113906297A (zh) 2022-01-07
KR20220009424A (ko) 2022-01-24
EP3969903A1 (en) 2022-03-23
WO2020230007A1 (en) 2020-11-19
BR112021022896A8 (pt) 2022-10-11
MX2021013956A (es) 2022-03-11
US11642300B2 (en) 2023-05-09
US20200360259A1 (en) 2020-11-19
CA3140604A1 (en) 2020-11-19
AU2020274637A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
BR112021022896A2 (pt) Método de seleção de regimes, ingredientes e composições de tratamento de pele
CL2020000075A1 (es) Carboxamidas como moduladores de los canales de sodio.
CO2022003782A2 (es) Inhibidores de kras g12d
DOP2020000021A (es) Anticuerpos anti-cd39, composiciones que comprenden anticuerpos anti-cd39, y métodos de uso de anticuerpos anti-cd39
DOP2019000005A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
CU20160017A7 (es) Métodos, kits y formulaciones para el tratamiento del cabello que usan sustancias activas que tienen un doble enlace carbono-carbono
PH12016502254A1 (en) Keratin treatment formulations and methods
BR112015019440A8 (pt) curativo regulável, kit, uso e método para fortalecimento da pele
NI202000080A (es) Inhibidores de magl
BR112012020229A2 (pt) "aparelho e método para obter teste clínico oftálmico de aberrações ópticas de alta ordem."
CL2019003398A1 (es) Inhibidores pirazólicos de magl.
BR112017004446A2 (pt) anticorpo específico a células cancerígenas, fármaco anticâncer e método de teste para constatação de câncer
BRPI0918313A2 (pt) Agente antiperspirante multicomponente, processo para tratar a perspiração humana, uso de um agente multicomponente e dispositivo com múltiplos compartimentos ou kit
BR112016015682A8 (pt) métodos e composições de xampu para tingimento gradual dos cabelos
EA202191513A1 (ru) Снижение вязкости фармацевтических составов
BR112018000012A2 (pt) sistema e método de avaliação de função endotelial
MX2020004837A (es) Inhibidores de la vía de adenosina para el tratamiento del cáncer.
AR094261A1 (es) Metodo para prueba de mal olor oral
BR112017019841A2 (pt) técnica de análise de amostra de tecido
CO2023006684A2 (es) Anticuerpos contra sars-cov-2 y usos de los mismos
BR112016029024A2 (pt) conjugados e composições de texafirina-pt(iv) para uso na superação da resistência à platina
CO2019009020A2 (es) Derivados de pirazol como inhibidores de bromodominio.
CY1122829T1 (el) Φαρμακευτικη συνθεση για νευροπαθητικο πονο
CL2020002519A1 (es) Composiciones de erenumab y usos de las mismas
BR112021015222A2 (pt) Métodos, sistemas e kits para tratamento de doença inflamatória de alvejamento de il18r1

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: CHENANGO ZERO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO ONE LLC (US) ; CHENANGO TWO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO ONE LLC (US) ; CURRAHEE HOLDING COMPANY INC. (US)

B25D Requested change of name of applicant approved

Owner name: CHENANGO ONE LLC (US) ; JOHNSON AND JOHNSON CONSUMER INC. (US)